Trial
NCT04050852
Pulmonary Function Test Changes and Respiratory Muscle Strength Trends in Spinal Muscular Atrophy Patients Receiving Nusinersen Treatments
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
Winthrop University Hospital
Condition
Spinal Muscular Atrophy
Intervention
Nusinersen Treatments
Why stopped
no enrolled prospects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-29